Literature DB >> 21050796

Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson's disease.

Yoshihiro Sato1, Jun Iwamoto, Yoshiaki Honda.   

Abstract

A high incidence of fractures, particularly of the hip, represents an important problem in patients with Parkinson's disease (PD), who are prone to falls and have osteoporosis. We previously showed that 25-hydroxyvitamin D (25-OHD) deficiency due to sunlight deprivation with compensatory hyperparathyroidism causes reduced bone mineral density (BMD) in elderly patients with PD. The present study was undertaken to address the possibility that sunlight exposure may maintain BMD and reduce the incidence of hip fracture in elderly patients with PD. In a prospective study, PD patients were assigned to regular sunlight exposure (n=162) or usual lifestyle (n=162), and followed for 2 years. BMD of the second metacarpal bone was measured using a computed X-ray densitometer. Incidence of hip fracture in the two patient groups during the 2 year follow-up period was assessed. At baseline, patients of both groups showed vitamin D deficiency due to sunlight deprivation with compensatory hyperparathyroidism. The exposed group patients were exposed to sunlight (3231 min/year). BMD increased by 3.8% in the sunlight-exposed group and decreased by 2.6% in the usual lifestyle group (p<.0001). Serum 25-OHD level increased from 27 nmol/L to 52 nmol/L in the sunlight-exposed group. Eleven patients sustained hip fracture in the normal lifestyle group, and 3 fractures occurred among the sunlight-exposed group (p=.03; odds ratio=2.4). Sunlight exposure can increase the BMD of vitamin D deficient bone by increasing 25-OHD concentration and leads to the prevention of hip fracture.
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21050796     DOI: 10.1016/j.parkreldis.2010.10.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

1.  Risk of fracture in patients with Parkinson's disease.

Authors:  S Pouwels; M T Bazelier; A de Boer; W E J Weber; C Neef; C Cooper; F de Vries
Journal:  Osteoporos Int       Date:  2013-02-22       Impact factor: 4.507

Review 2.  Musculoskeletal problems in Parkinson's disease.

Authors:  Young Eun Kim; Beom S Jeon
Journal:  J Neural Transm (Vienna)       Date:  2013-02-19       Impact factor: 3.575

3.  Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis.

Authors:  Jun Iwamoto; Kaori Yago; Yoshihiro Sato; Hideo Matsumoto
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

4.  Bone mineral density and vitamin D status in Parkinson's disease patients.

Authors:  F van den Bos; A D Speelman; M van Nimwegen; Y T van der Schouw; F J G Backx; B R Bloem; M Munneke; H J J Verhaar
Journal:  J Neurol       Date:  2012-10-09       Impact factor: 4.849

5.  The influence of age at menarche on cross-sectional geometry of bone in young adulthood.

Authors:  Maja Sešelj; Ramzi W Nahhas; Richard J Sherwood; Wm Cameron Chumlea; Bradford Towne; Dana L Duren
Journal:  Bone       Date:  2012-04-05       Impact factor: 4.398

6.  Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.

Authors:  Y-F Huang; Y-G Cherng; S P C Hsu; C-C Yeh; Y-C Chou; C-H Wu; T-L Chen; C-C Liao
Journal:  Osteoporos Int       Date:  2015-02-12       Impact factor: 4.507

Review 7.  Interventions for preventing falls in Parkinson's disease.

Authors:  Natalie E Allen; Colleen G Canning; Lorena Rosa S Almeida; Bastiaan R Bloem; Samyra Hj Keus; Niklas Löfgren; Alice Nieuwboer; Geert Saf Verheyden; Tiê P Yamato; Catherine Sherrington
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

8.  Strategy for prevention of hip fractures in patients with Parkinson's disease.

Authors:  Jun Iwamoto; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  World J Orthop       Date:  2012-09-18

9.  Serum 25-hydroxyvitamin D3 concentration in Iranian patients with Parkinson's disease.

Authors:  Mehdi Moghaddasi; Mansoureh Mamarabadi; Mahboubeh Aghaii
Journal:  Iran J Neurol       Date:  2013

10.  Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease.

Authors:  Juan Wang; Deyu Yang; Yu Yu; Gaohai Shao; Qunbo Wang
Journal:  Nutrients       Date:  2016-03-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.